What Does Lichen Planus in the Eye Look Like?

Lichen planus in the eye can look strikingly different depending on which part of the eye it affects, but the most recognized presentations include violet-colored scaly plaques on the eyelids and a red, inflamed conjunctiva that gradually develops white scar tissue beneath the surface. Because the condition is rare and can mimic several other eye diseases, many cases go unrecognized until scarring has already progressed. The appearance shifts as the disease advances, starting subtly with redness and irritation and potentially ending with structural distortions visible even without magnification.

What It Looks Like on the Eyelids

When lichen planus (LP) targets the eyelid skin, it produces the same type of lesions seen elsewhere on the body. A case report documented multiple well-defined violaceous, thin, scaly plaques across both the upper and lower eyelids on both sides of the face.¹ “Violaceous” in plain terms means a dusky purple-violet color, and the plaques tend to be flat or only slightly raised, with a fine flaky scale on the surface. They look quite similar to LP patches found on wrists or shins, but on the thin eyelid skin they can be more translucent and easier to miss during a quick exam.

Not everyone with ocular LP gets these classic-looking plaques, though. Some people only experience irritation of the eyelid margins, blepharitis (crusting and redness along the lash line), and a gritty sensation, without ever developing the purple patches that would tip off a dermatologist.² This subtler form is a big reason why eyelid LP often gets mistaken for common blepharitis or another skin condition entirely.

What It Looks Like on the Conjunctiva

The conjunctiva, the clear membrane that lines the inner eyelids and covers the white of the eye, is the structure most commonly affected in ocular LP. Early on, the conjunctiva appears red and irritated, a finding doctors call conjunctival injection. In one reported case, a patient presented with bilateral conjunctival redness graded as moderate, along with diffuse fine scratches across the corneal surface and dysfunction of the oil glands in the eyelid margins.³ At this stage, the eye simply looks bloodshot and uncomfortable, which is why it can be confused with allergies, dry eye, or rosacea-related inflammation.

What distinguishes LP from those conditions is what happens next. The inflammatory process drives scar tissue to form beneath the conjunctival surface. Under a slit lamp, an ophthalmologist can see whitish bands of fibrous tissue developing in the tissue that normally stays loose and flexible. This scarring process, called cicatrization, is the hallmark of conjunctival LP and the feature that makes the disease potentially sight-threatening.⁴

How the Scarring Progresses

Most reported cases of ocular LP involve cicatricial conjunctivitis, meaning the conjunctiva becomes progressively scarred. The scarring brings a cascade of visible structural changes. Subepithelial fibrosis, where dense fibrous tissue builds beneath the conjunctival lining, is the first recognizable step. The fornices (the deep pockets where the inner eyelid meets the eyeball) begin to shorten as scar tissue contracts, pulling the tissue tighter. Eventually, bands of scar tissue called symblepharons form, physically fusing the inner eyelid surface to the surface of the eyeball.⁵

One detailed case description captured these changes vividly: subepithelial fibrosis of the upper inner eyelid, symblepharon formation in the lower inner eyelid, significant conjunctival injection across the surface of the eyeball, and corneal pannus (new blood vessels growing into the normally clear cornea from the top) along with severe punctate erosions scattered across the corneal surface.⁶ By this stage, the eye looks visibly abnormal even without magnification: the lids may not close fully, the white of the eye appears persistently red, and the cornea can look hazy or clouded where blood vessels have invaded.

The scarring can also involve the lacrimal structures, the tiny drainage channels for tears. When those scar shut, the eye paradoxically becomes both watery (tears can’t drain) and dry (the glands producing healthy tear film have been damaged).² This combination of watering and severe dryness confuses patients and clinicians alike.

Effects on the Cornea and Tear Film

Even before visible scarring appears, LP can quietly damage the eye’s surface. Research comparing LP patients to healthy controls found that people with LP had lower tear production and faster tear break-up times, meaning the tear film evaporated more quickly off the eye surface. These problems worsened the longer a person had the disease, and were more pronounced in patients who also had oral LP involvement.⁷ Symptoms at this stage include burning, a sandy or gritty feeling, sensitivity to light, and blurred vision that improves briefly after blinking.

When the cornea itself becomes involved, the condition is called keratitis. Punctate erosions (tiny pits in the corneal surface visible with special dye under a blue light) are common. In severe cases, the corneal surface can break down entirely. One report documented a corneal perforation, a full-thickness hole through the cornea, associated with isolated ocular LP. That patient required aggressive lubrication, corneal healing agents, topical tacrolimus, and systemic immunosuppression with corticosteroids and cyclophosphamide to stabilize the eye.⁸ Corneal perforation is the extreme end of the spectrum, but it underscores how much damage uncontrolled LP can do.

Whether the corneal damage happens directly from LP inflammation or secondarily from the scarring and dryness caused by conjunctival disease is still debated.⁵ In practice, both routes probably contribute. The scarred conjunctiva disrupts normal blinking mechanics and tear distribution, which leaves the cornea exposed to chronic micro-trauma even if the cornea itself is not a primary target of the inflammatory process.

Why It Gets Misdiagnosed

Ocular LP is extremely rare. A literature review counted only 22 previously published cases before adding the 23rd. Of those, roughly 83% were in women, and about a quarter had LP only in the eye with no skin or mouth involvement at all.² When someone walks into a clinic with a red, irritated eye and no purple patches on their skin or white streaks in their mouth, LP is not high on the diagnostic list.

The scarring pattern of conjunctival LP is clinically indistinguishable from several other diseases that scar the conjunctiva. The differential diagnosis is long. It includes autoimmune conditions like mucous membrane pemphigoid and linear IgA disease, as well as graft-versus-host disease, Stevens-Johnson syndrome, trachoma, rosacea, allergic conjunctivitis, and even certain cancers of the eyelid glands.⁹ A clinician seeing a scarring conjunctivitis is far more likely to think of mucous membrane pemphigoid first, because it is more common. Distinguishing LP from these conditions based on appearance alone is often impossible, and getting the diagnosis right matters because treatment strategies differ.¹⁰

In at least one documented case, a patient’s ocular LP was initially misdiagnosed and treated as rosacea. The patient had blepharitis, symblepharon, conjunctival redness, surface damage, and corneal blood vessel growth, all features that overlap with ocular rosacea but were actually caused by LP.¹¹ The delay in correct diagnosis meant the scarring had time to advance before appropriate immunosuppressive treatment began.

How It Is Confirmed

Because the clinical appearance is ambiguous, biopsy is typically necessary. A small piece of conjunctival tissue is taken and examined under a microscope. Classic LP histopathology shows a band-like collection of inflammatory cells (lymphocytes) just beneath the surface lining, with damage to the bottom layer of those lining cells. The basement membrane, the thin structural sheet that anchors the surface cells, often appears thickened and irregular, with reduplications that resemble the pattern seen in oral LP.¹²

Direct immunofluorescence testing, where the tissue sample is treated with fluorescent antibodies to look for specific immune deposits, adds another layer of confirmation. LP characteristically shows heavy deposits of fibrinogen in a shaggy pattern along the basement membrane, without the IgG, IgA, IgM, or complement deposits that would point to mucous membrane pemphigoid or other autoimmune blistering diseases.¹³ ¹⁴ This fibrinogen-positive, immunoglobulin-negative pattern is the most reliable way to separate LP from its look-alikes on the conjunctiva.

The Multi-Site Connection

LP is a systemic inflammatory condition, and involvement in one area often signals disease elsewhere. A large study evaluating patients with oral LP found that a meaningful proportion had the disease in multiple sites: skin involvement was the most common extraoral finding, followed by genital disease in about 19% of women and close to 5% of men examined. Conjunctival LP was identified in only one patient out of the entire cohort, confirming how uncommon eye involvement truly is.¹⁵

Despite its rarity, when ocular LP does appear, it tends to occur in people with severe, erosive disease affecting multiple mucosal surfaces. A study examining lacrimal duct scarring in LP patients found that all nine women in the cohort had biopsy-proven LP at other body sites, and seven of the nine had vulvovaginal-gingival syndrome, an aggressive erosive form of LP.¹⁶ If you already have erosive LP in your mouth or genital area, your ophthalmologist should be aware, because even subtle eye symptoms in that context warrant closer investigation.

Treatment and How Quickly It Can Work

There is no cure for ocular LP, but immunosuppressive treatment can halt or slow the scarring process. Treatment decisions usually involve collaboration between ophthalmology, dermatology, and sometimes rheumatology. The specific regimen depends on severity. In mild cases, topical therapies and aggressive lubrication may suffice. In one severe case where both the mouth and eyes were significantly affected, a multidisciplinary team chose azathioprine as a long-term steroid-sparing agent alongside a short course of oral corticosteroids. Within a month, the patient’s visual acuity improved dramatically, rising from 20/150 to 20/40 in the worse eye and from 20/80 to 20/20 in the better eye. At twelve months of follow-up, the disease remained stable without progression of scarring and with significant relief of discomfort.³

That kind of visual recovery is encouraging but depends heavily on how much scarring has already occurred before treatment starts. The inflammatory component of the disease can often be dialed down effectively, but scar tissue that has already formed does not reverse. This is why early diagnosis matters so much, and why the misdiagnosis problem discussed earlier carries real consequences for patients.

For advanced cases with severe corneal surface damage, scleral contact lenses may play a role in protecting the fragile ocular surface and improving functional vision. These large-diameter lenses vault over the entire cornea, resting on the white of the eye, and create a fluid reservoir that keeps the damaged corneal surface hydrated throughout the day. Evidence for their use in cicatricial conjunctivitis is limited to small case series, but they have become an accepted option for surface protection and visual rehabilitation in these patients.¹⁷

Drug-Induced Ocular LP

An unusual wrinkle in this topic is that certain medications can trigger LP in the eye. One documented case involved brimonidine, a common glaucoma eye drop. The patient developed unilateral (one-sided) conjunctival LP only in the eye receiving the drop. Biopsy confirmed classic LP histopathology, and immunofluorescence showed the characteristic shaggy fibrinogen deposits without other immune deposits.¹⁴ Drug-induced LP is well recognized at other body sites (certain blood pressure medications and anti-malarials are known triggers), but a topical eye drop causing localized LP directly on the conjunctiva is a particularly striking example. The one-sided involvement in a patient using drops in that eye was the key clue. If you develop new redness, irritation, or scarring in one eye while using long-term eye drops, it is worth mentioning to your doctor.

What to Watch For If You Have LP Elsewhere

Because ocular LP is so rare, routine eye screening of every person with skin or oral LP is not standard practice. However, research showing that LP patients as a group have measurably reduced tear production and faster tear evaporation compared to healthy people suggests that subclinical eye surface changes may be more common than recognized cases would imply.⁷ The longer you have had LP and the more mucosal surfaces it affects, the stronger the association with eye surface problems.

Symptoms that should prompt an eye exam include persistent redness that does not respond to standard dry eye treatments, a sensation of something in the eye, progressive blurring not correctable with glasses, tearing combined with dryness, and any visible whitish tissue changes on the inner eyelid surface. These symptoms are nonspecific on their own, but in someone already diagnosed with LP, they take on a different significance. The goal is to catch the disease before significant scarring sets in, because the structural damage from cicatrization, once established, is permanent.²

1
PubMed Central. Lichen Planus of the Eyelids: Case Report of a Rare Presentation of a Common Dermatosis
2
PubMed Central. Ocular lichen planus: An unusual presentation, its treatment, and review of the literature
3
American Journal of Case Reports. Erosive Lichen Planus With Ocular Involvement: A Case Report
4
Clinical and Experimental Dermatology. Conjunctival impression cytology, ocular surface and tear‐film changes in patients with lichen planus
5
PubMed. Lichen Planus in Ocular Surface: Major Presentations and Treatments
6
PubMed Central. Cicatricial keratoconjunctivitis associated with lichen planus
7
PubMed Central. Evaluation of ocular findings in patients with lichen planus
8
PubMed. Corneal perforation associated with isolated ocular lichen planus: a case report
9
Indian Journal of Ophthalmology – Case Reports. Isolated conjunctival lichen planus: A rare cause of cicatrizing conjunctivitis
10
American Journal of Ophthalmology. Lichen planus and cicatrizing conjunctivitis: characterization of five cases
11
Austin Ophthalmology. A Rare Case of Isolated Ocular Lichen Planus
12
PubMed. Immunohistopathologic features and therapy of conjunctival lichen planus
13
PubMed. Isolated ocular lichen planus in a child
14
Arquivos Brasileiros de Oftalmologia. Brimonidine-induced unilateral ocular lichen planus: a case report
15
PubMed. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus
16
JAMA Dermatology. Lacrimal Canalicular Duct Scarring in Patients With Lichen Planus
17
PubMed Central. Update on indications, complications, and outcomes of scleral contact lenses